2020
DOI: 10.18632/oncotarget.27488
|View full text |Cite
|
Sign up to set email alerts
|

MAGE-A inhibit apoptosis and promote proliferation in multiple myeloma through regulation of BIM and p21Cip1

Abstract: The type I Melanoma Antigen Gene (MAGE) A3 is a functional target associated with survival and proliferation in multiple myeloma (MM). To investigate the mechanisms of these oncogenic functions, we performed gene expression profiling (GEP) of p53 wildtype human myeloma cell lines (HMCL) after MAGE-A knockdown, which identified a set of 201 differentially expressed genes (DEG) associated with apoptosis, DNA repair, and cell cycle regulation. MAGE knockdown increased protein levels of pro-apoptotic BIM and of th… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
9
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 13 publications
(9 citation statements)
references
References 42 publications
0
9
0
Order By: Relevance
“…Further, MAGE-A2 can form a complex with estrogen receptor (ER)-α, either directly or via ER cofactors, and enhance its transcriptional activity [77]. MAGE-A-mediated suppression of p53 can suppress the expression of pro-apoptotic proteins such as BIM and p21 Cip1 in multiple myeloma [97]. Interestingly, MAGE-A3 can interact with long noncoding RNA (LINC01234) and microRNA (microRNA-31-5p) to facilitate proliferation and chemoresistance in hepatocellular carcinoma [98].…”
Section: Discussionmentioning
confidence: 99%
“…Further, MAGE-A2 can form a complex with estrogen receptor (ER)-α, either directly or via ER cofactors, and enhance its transcriptional activity [77]. MAGE-A-mediated suppression of p53 can suppress the expression of pro-apoptotic proteins such as BIM and p21 Cip1 in multiple myeloma [97]. Interestingly, MAGE-A3 can interact with long noncoding RNA (LINC01234) and microRNA (microRNA-31-5p) to facilitate proliferation and chemoresistance in hepatocellular carcinoma [98].…”
Section: Discussionmentioning
confidence: 99%
“…We for the first time demonstrate that C19MC miRNA-520G promotes the expression of MAGEA-3, 6 and 12 in p53-defective cells and that C19MC miRNAs are overexpressed in p53 transcriptionally incompetent HCC tumors. Defects in p53 transcription can result in impaired apoptosis and enhanced cellular transformation 36 , 37 and MAGEAs are known to inhibit p53 and p21 (a p53 transcriptional target) -induced apoptosis 38 . Although p53 is known to have defects in Hep3B cells, the exact nature of p53 defect in Hep3B cells was not known.…”
Section: Discussionmentioning
confidence: 99%
“…In contrast, inhibitory effect of MAGEs on apoptosis has also been reported: MAGEA3 was shown to promote proliferation while suppressing apoptosis of cervical cancer cells [ 22 ]. Similarly, it was shown that MAGEA3 suppresses apoptosis of multiple myeloma cells [ 23 ], and MAGE-C suppresses apoptosis of melanoma and colon cancer cell lines [ 24 ]. These reports collectively indicate that each member of MAGEs may play a different role in apoptosis.…”
Section: Discussionmentioning
confidence: 99%